These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24010937)

  • 1. Ligand based validated comparative chemometric modeling and pharmacophore mapping of aurone derivatives as antimalarial agents.
    Adhikari N; Halder AK; Mondal C; Jha T
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):417-32. PubMed ID: 24010937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of important sites of antimalarial Endochins for optimum structural modification using group-based QSAR (G-QSAR) modeling.
    Ojha PK; Roy K
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):336-49. PubMed ID: 24010932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore Identification and QSAR Studies on Substituted Benzoxazinone as Antiplatelet Agents: kNN-MFA Approach.
    Choudhari PB; Bhatia MS; Jadhav SD
    Sci Pharm; 2012; 80(2):283-94. PubMed ID: 22896816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR modeling for the antimalarial activity of 1,4-naphthoquinonyl derivatives as potential antimalarial agents.
    Luan F; Xu X; Cordeiro MN; Liu H; Zhang X
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):95-107. PubMed ID: 23157413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR modeling for quinoxaline derivatives using genetic algorithm and simulated annealing based feature selection.
    Ghosh P; Bagchi MC
    Curr Med Chem; 2009; 16(30):4032-48. PubMed ID: 19747124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR and pharmacophore modeling of natural and synthetic antimalarial prodiginines.
    Singh B; Vishwakarma RA; Bharate SB
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):350-9. PubMed ID: 24010933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of antimalarial drug research with special reference to application of QSAR models.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):91-128. PubMed ID: 25543681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
    Sharma MC
    Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors.
    Tseng TS; Lee YC; Hsiao NW; Liu YR; Tsai KC
    Bioorg Med Chem Lett; 2016 Jan; 26(2):265-271. PubMed ID: 26707392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report on exploring structural requirements of 1,2,3,4- tetrahydroacridin-9(10H)-one analogs as antimalarials using multiple QSAR approaches: descriptor-based QSAR, CoMFA-CoMSIA 3DQSAR, HQSAR and G-QSAR approaches.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2013 Jan; 16(1):7-21. PubMed ID: 23127758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions.
    Prasanth Kumar S; Jasrai YT; Pandya HA; Rawal RM
    J Biomol Struct Dyn; 2015; 33(1):56-69. PubMed ID: 24266725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
    Roy K; Mandal AS
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring clotrimazole-based pharmacophore: 3D-QSAR studies and synthesis of novel antiplasmodial agents.
    Brogi S; Brindisi M; Joshi BP; Sanna Coccone S; Parapini S; Basilico N; Novellino E; Campiani G; Gemma S; Butini S
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5412-8. PubMed ID: 26428874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring structural requirements for a class of nucleoside inhibitors (PfdUTPase) as antimalarials: first report on QSAR, pharmacophore mapping and multiple docking studies.
    Ojha PK; Roy K
    Comb Chem High Throughput Screen; 2013 Nov; 16(9):739-57. PubMed ID: 23701009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
    Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
    Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIA-QSAR coupled to different regression methods for the modeling of antimalarial activities of 2-aziridinyl and 2,3-bis-(aziridinyl)-1,4-naphtoquinonyl sulfate and acylate derivatives.
    Goodarzi M; Freitas MP
    Med Chem; 2011 Nov; 7(6):645-54. PubMed ID: 22313304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.